NUS Centre for Cancer Research (N2CR)

Dear NUS Cancer Researchers & Students, You are cordially invited to our Precision Cancer Medicine (PCM) Invited Speaker Seminar on coming Friday (29 Nov 2024): Venue: MD4-02-03E - Seminar Room, Level 2, MD4 Microbiology, NUS Time: 3 - 4 pm Talk Title: Chance and Necessity: Decision Making in Single Cancer Cells during Therapy Resistance Speaker: Dr. Yogesh Goyal Host: Dr. Shruti Bhatt NUS Yong Loo Lin School of Medicine Cancer Science Institute of Singapore See you there!

Excited to have attended the NUSMedSci Alliance launch today. This incredible initiative brings together everyone in the research community, including all the NUS Translational Research Programmes (TRPs), to create a vibrant ecosystem for medical and health science research. Excited for the innovative breakthroughs and collaborations ahead! #NUSMedAlliance #NUSMedicine #NUSResearch

New study by our N2CR members, led by A/Prof Alfredo Franco-Obregón, and co-first authors, Viresh Krishnan Sukumar (N2CR PhD Scholarship student) and Dr Yee Kit Alex Tai, shows targeted magnetic fields enhance doxorubicin (a chemotherapy drug) uptake in cancer cells without affecting healthy tissues. This could reduce systemic doses and improve patient outcomes. A potential game changer in cancer treatment. https://bit.ly/4fUtE48 #breastcancertreatment #cancerresearch #magneticfieldtherapy #nusresearch #PhD

Study by our N2CR members reveals how extracellular vesicles (EVs) from drug-resistant tumours induce resistance and enhance invasiveness in cells, highlighting potential diagnostic and therapeutic targets. Click to read more: www.thno.org/v14p6350.htm #cancerresearch #NUSresearch

We are excited to share that N2CR has been invited by the Ministry of Education, Singapore (MOE) - Partnership Engagement Office - to attend the 'School-Industry Partnership Appreciation and Networking Event', in recognition of our educational outreach programme, “Inspiring Young Minds: A Day in the World of Cancer Research and Healthcare” which was held in May 2024. This initiative was aimed at secondary school students and was well-received by both the students and teachers for its engaging and informative content. Our Outreach Chair, A/Prof Norbert Lehming, and Admin Lead, Dr Yam Xue Yan, represented N2CR at the appreciation evening. We look forward to continuing our efforts in 2025 and hope to inspire and engage the next generation on the exciting possibilities in scientific research and healthcare. Watch and read what our fellow educators had to say about the outreach programme : //bit.ly/3Cl9dyI #Education #MOE #ChanChunSing

Congratulations Dr Minh Le and team!

How can we tackle drug resistance to provide cancer patients with lasting relief? And what strategies are emerging to outsmart cancer’s relentless evolution? I penned an article, "Cancer Drug Resistance: Current Insights and Future Outlook （抗癌之战：药物耐药性的现状与未来）" published today in the Chinese newspaper Lianhe Zaobao (联合早报), to address these questions. In this piece, I highlight the immense challenge of drug resistance in cancer care while exploring how advances in medicine and technology may reshape cancer treatment. Cancer research continues to evolve, and I am optimistic about the possibilities these innovative strategies offer for patients worldwide. Here is the link to the article: https://lnkd.in/gJUqHzS9 You can read the PDF version below. I have also translated this article into English - it will be available to read soon. Many thanks to Yingzhu from Zaobao and Gladys from NUS YLL School of Medicine Corp Comm for their invaluable support in publishing this article! #N2CR #NUSMedicine

🌟 Exciting Opportunity! 🔍 Our multidisciplinary research team is seeking a passionate Research Assistant to profile #MultipleMyeloma and establish long-term 3D #CancerOrganoid for #DrugTesting. If you have a strong background in cell biology and a desire to contribute to groundbreaking cancer research, we want to hear from you! Join us in making a difference within a collaborative and innovative environment. Please reach out or share this opportunity with anyone who might be a great fit! Please write to me for more info, or to check out the job description here. Cancer Science Institute of Singapore N2CR - Cancer Translational Research Programme

DriverDetect, a machine learning algorithm, enhances cancer mutation prediction by combining outputs from seven tools, outperforming individual methods and adapting to new data for broad cancer analysis. Click here to read more: bit.ly/4ftkdIG #AI #machinelearning #cancer

The latest issue of N2CR INSIGHTS is out and brings you highlights of our research and latest happenings. Click to read: https://bit.ly/4foqYeL Happy reading!